The COVID-19 pandemic has brought into focus the importance of pandemic preparedness and response. It is testing the strength of societies and health systems around the world and is currently among the highest priorities for U.S. and global public health and safety.
FHI 360 addresses emerging pandemics and epidemics with expertise that supports health security efforts in the United States and globally, improving epidemic preparedness, detection and response. We incorporate technological innovations and use cutting-edge behavioral, sociomedical, epidemiological, laboratory and clinical research sciences to understand, prevent and contain these emerging threats.
FHI 360 has worked on outbreak preparedness and response for several pandemic threats, including COVID-19, new influenza strains like the avian flu and H1N1, Dengue fever, Ebola and Zika.
Our cross-cutting capabilities to control pandemic threats include:
- Clinical laboratory quality assurance
- Clinical trials design and implementation
- Food security and emergency nutrition
- Health surveillance
- Health systems strengthening
- Humanitarian response
- Infectious and tropical diseases
- Product quality and compliance
- Social and behavior change communication, risk communication and social marketing and communications
- Water, sanitation and hygiene
- One Health
